4.4 Review

A Systematic Review of Research Gaps in the Evaluation and Management of Localized Renal Masses

Journal

UROLOGY
Volume 98, Issue -, Pages 14-20

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.urology.2016.08.013

Keywords

-

Funding

  1. Agency for Healthcare Research and Quality [HHSA2902012000071]
  2. U.S. Department of Health and Human Services

Ask authors/readers for more resources

The management of clinically localized renal masses suspicious for renal cell carcinoma varies, partially because of gaps in the evidence base. We conducted a systematic review to summarize research gaps for the evaluation of composite models for predicting malignancy; use of percutaneous renal sampling for diagnosis; and comparative effectiveness of surgery, thermal ablation, and active surveillance. A total of 147 studies, published in 150 articles, were identified. To promote improved patient care and health outcomes, we recommend incorporation of emerging biomarkers into validated composite models, standardization of biopsy protocols, standard reporting of clinical stage, and performance of prospective studies with objective selection criteria. (C) 2016 Elsevier Inc.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

Risk of prostate cancer for men with prior negative biopsies undergoing magnetic resonance imaging compared with biopsy-naive men: A prospective evaluation of the PLUM cohort

Hiten D. Patel, Elizabeth L. Koehne, Steven M. Shea, Yasin Bhanji, Marielia Gerena, Alex Gorbonos, Marcus L. Quek, Robert C. Flanigan, Ari Goldberg, Gopal N. Gupta

Summary: Men with prior negative prostate biopsies have a lower risk of being diagnosed with prostate cancer, and decision curve analyses suggest that many unnecessary biopsies can be avoided by using the PLUM models or a PI-RADS 4 cutoff.

CANCER (2022)

Article Urology & Nephrology

Four versus 3 Cycles of Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: Implications for Pathological Response and Survival

Hiten D. Patel, Sunil H. Patel, Enrique Blanco-Martinez, Jake Kuzbel, Victor S. Chen, Aleksander Druck, Elizabeth L. Koehne, Parth M. Patel, Chirag P. Doshi, Noah M. Hahn, Jean H. Hoffman-Censits, Stephanie Berg, Trinity J. Bivalacqua, Max Kates, Marcus L. Quek

Summary: Patients with muscle-invasive bladder cancer who completed 3 cycles of cisplatin-based neoadjuvant chemotherapy showed similar pathological response and short-term survival compared to those who completed 4 cycles.

JOURNAL OF UROLOGY (2022)

Article Urology & Nephrology

A prostate biopsy risk calculator based on MRI: development and comparison of the Prospective Loyola University multiparametric MRI (PLUM) and Prostate Biopsy Collaborative Group (PBCG) risk calculators

Hiten D. Patel, Elizabeth L. Koehne, Steven M. Shea, Andrew M. Fang, Marielia Gerena, Alex Gorbonos, Marcus L. Quek, Robert C. Flanigan, Ari Goldberg, Soroush Rais-Bahrami, Gopal N. Gupta

Summary: A prostate cancer risk calculator incorporating multiparametric magnetic resonance imaging (mpMRI) has been developed and validated, outperforming other risk calculators in diagnosing high-risk prostate cancer and potentially reducing unnecessary biopsies.

BJU INTERNATIONAL (2023)

Review Urology & Nephrology

Impact of the COVID-19 pandemic on the kidney community: lessons learned and future directions

Duvuru Geetha, Andreas Kronbichler, Megan Rutter, Divya Bajpai, Steven Menez, Annemarie Weissenbacher, Shuchi Anand, Eugene Lin, Nicholas Carlson, Stephen Sozio, Kevin Fowler, Ray Bignall, Kathryn Ducharlet, Elliot K. Tannor, Eranga Wijewickrama, Muhammad I. A. Hafiz, Vladimir Tesar, Robert Hoover, Deidra Crews, Charles Varnell, Lara Danziger-Isakov, Vivekanand Jha, Sumit Mohan, Chirag Parikh, Valerie Luyckx

Summary: This review summarizes the challenges and missed opportunities in caring for patients with kidney disease during the COVID-19 pandemic. It discusses the impact on patients and clinicians, including increased infection risk and resource shortages, and provides a framework for management and support.

NATURE REVIEWS NEPHROLOGY (2022)

Correction Urology & Nephrology

Impact of the COVID-19 pandemic on the kidney community: lessons learned and future directions (vol 18, pg 417, 2022)

Duvuru Geetha, Andreas Kronbichler, Megan Rutter, Divya Bajpai, Steven Menez, Annemarie Weissenbacher, Shuchi Anand, Eugene Lin, Nicholas Carlson, Stephen Sozio, Kevin Fowler, Ray Bignall, Kathryn Ducharlet, Elliot K. Tannor, Eranga Wijewickrama, Muhammad I. A. Hafidz, Vladimir Tesar, Robert Hoover, Deidra Crews, Charles Varnell, Lara Danziger-Isakov, Vivekanand Jha, Sumit Mohan, Chirag Parikh, Valerie Luyckx

NATURE REVIEWS NEPHROLOGY (2022)

Review Public, Environmental & Occupational Health

A review of infectious disease epidemiology in emergency medical service clinicians

Anna Russell, J. Lee Jenkins, Allen Zhang, Lisa M. Wilson, Eric B. Bass, Edbert B. Hsu

Summary: This review examined the prevalence, incidence, and severity of infections among the emergency medical service (EMS) workforce. The majority of studies focused on SARS-CoV-2 infection, with varying prevalence rates. MRSA and Hepatitis C infections were also reported. Limited studies reported incidence rates. Differences in infection rates were observed between EMS clinicians and firefighters, with higher hospitalization or death rates for SAR-CoV-2 and higher prevalence of Hepatitis C among EMS clinicians. More research is needed to understand the incidence and severity of occupationally-acquired infections in the EMS workforce.

AMERICAN JOURNAL OF INFECTION CONTROL (2023)

Article Oncology

MRI versus non-MRI diagnostic pathways before radical prostatectomy: Impact on nerve-sparing, positive surgical margins, and biochemical recurrence

Hiten D. Patel, Yudai Okabe, Goran Rac, Gaurav Pahouja, Shalin Desai, Steven M. Shea, Alex Gorbonos, Marcus L. Quek, Robert C. Flanigan, Ari Goldberg, Gopal N. Gupta

Summary: This study compared the impact of MRI vs. non-MRI diagnostic pathways on surgical outcomes for patients undergoing radical prostatectomy (RP). The results showed that MRI-based diagnostic approach was associated with lower positive surgical margin rates, higher utilization of bilateral nerve-sparing, and improved cancer control by biochemical recurrence.

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2023)

Article Oncology

Disparities in access to robotic technology and perioperative outcomes among patients treated with radical prostatectomy

Charles D. Logan, Ashorne K. Mahenthiran, Mohammad R. Siddiqui, Dustin D. French, Matthew T. Hudnall, Hiten D. Patel, Adam B. Murphy, Joshua A. Halpern, David J. Bentrem

Summary: Most radical prostatectomies are done with robotic assistance. This study examined disparities in access and outcomes of robot-assisted radical prostatectomy (RARP) and found that non-Hispanic Black and Hispanic patients were less likely to receive RARP, and underinsured patients had lower rates of RARP. RARP was associated with decreased perioperative mortality and improved overall survival compared to open radical prostatectomy (ORP).

JOURNAL OF SURGICAL ONCOLOGY (2023)

Article Oncology

Cause-specific mortality among patients with renal cell carcinoma in the United States from 2000 to 2018

Anas Elgenidy, Ahmed K. Awad, Huzaifa Ahmad Cheema, Abia Shahid, Salah Eddine Oussama Kacimi, Mostafa G. Aly, Nirmish Singla, Ahmed M. Afifi, Hiten D. Patel

Summary: This study aimed to assess the frequency and risk of different causes of death in patients with renal cell carcinoma (RCC) in the United States. The majority of deaths were due to kidney cancer, but a significant proportion was caused by non-cancerous reasons. The proportion of deaths attributed to RCC decreased with increasing follow-up, and cardiovascular diseases and cerebrovascular diseases were the most common non-RCC-related causes of death. Coordination of multidisciplinary care is needed to prevent death from non-cancerous causes, depending on the stage of the disease.

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2023)

Article Medicine, Research & Experimental

T cell metabolic reprogramming in acute kidney injury and protection by glutamine blockade

Kyungho Lee, Elizabeth A. Thompson, Sepideh Gharaie, Chirag H. Patel, Johanna T. Kurzhagen, Phillip M. Pierorazio, Lois J. Arend, Ajit G. Thomas, Sanjeev Noel, Barbara S. Slusher, Hamid Rabb

Summary: T cells in acute kidney injury (AKI) undergo metabolic reprogramming, and targeting the T cell glutamine pathway could be a promising therapeutic approach. Ischemic AKI in mice showed the presence of a distinct T cell subset with altered expression of certain metabolic proteins. Similarly, human nonischemic and ischemic kidney tissue exhibited similar findings. Inhibition of glutamine with JHU083 attenuated renal injury and reduced T cell activation and proliferation in AKI.

JCI INSIGHT (2023)

Article Urology & Nephrology

Development and Validation of a Formative Assessment Tool for Nephrology Fellows' Clinical Reasoning

Suzanne M. Boyle, James Martindale, Andrew S. Parsons, Stephen M. Sozio, Rachel Hilburg, Jehan Bahrainwala, Lili Chan, Lauren D. Stern, Karen M. Warburton

Summary: This study developed and validated an instrument to assess clinical reasoning in nephrology fellows. The results showed that the majority of fellows met the criteria for coaching in at least one reasoning domain, highlighting the need for learner assessment and instruction in clinical reasoning.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2023)

Article Education & Educational Research

The association of a scholarly concentrations program with medical students' matched residencies

Hosam H. Alkhatib, Mary Catherine Beach, Kelly A. Gebo, Eric B. Bass, Jenny R. Park, Meredith A. Atkinson, Sapna R. Kudchadkar, Stephen M. Sozio

Summary: This study examined the association between medical school Scholarly Concentrations (SC) programs and students' specialty choices. The results showed that students' interest in a specialty at baseline and their research productivity with SC mentors were associated with increased odds of entering a related specialty. However, completing an SC project did not increase the odds of matching into that specialty or a higher ranked program.

MEDICAL EDUCATION ONLINE (2023)

Article Oncology

Neoadjuvant Nivolumab in Patients with High-risk Nonmetastatic Renal Cell Carcinoma

Michael A. Gorin, Hiten D. Patel, Steven P. Rowe, Noah M. Hahn, Hans J. Hammers, Alice Pons, Bruce J. Trock, Phillip M. Pierorazio, Thomas R. Nirschl, Daniela C. Salles, Julie E. Stein, Tamara L. Lotan, Janis M. Taube, Charles G. Drake, Mohamad E. Allaf

Summary: In this study, the safety and tolerability of preoperative administration of three doses of the immune checkpoint inhibitor nivolumab in patients with clinically localized high-risk renal cell carcinoma were evaluated. The study demonstrated the safety of this approach and found that a subset of patients may have features of an immune-related pathologic response.

EUROPEAN UROLOGY ONCOLOGY (2022)

Article Urology & Nephrology

Minimally invasive retroperitoneal lymph node dissection for men with testis cancer: a retrospective cohort study of safety and feasibility

Christian D. Fankhauser, Luca Afferi, Sean P. Stroup, Nicholas R. Rocco, Kathleen Olson, Aditya Bagrodia, Fady Baky, Walter Cazzaniga, Erik Mayer, David Nicol, Ekrem Islamoglu, Stephane de Vergie, Ragheed Saoud, Scott E. Eggener, Sebastiano Nazzani, Nicola Nicolai, Lee Hugar, Wade J. Sexton, Deliu-Victor Matei, Ottavio De Cobelli, Joseph Cheaib, Phillip M. Pierorazio, James Porter, Thomas Hermanns, Robert J. Hamilton, Andreas Hiester, Peter Albers, Noel Clarke, Agostino Mattei

Summary: The study aims to describe the perioperative safety, functional, and immediate post-operative oncological outcomes of minimally invasive RPLND (miRPLND) for testis cancer. The results show that miRPLND has a positive impact on postoperative ejaculatory function and a low proportion of complications and peritoneal recurrences, supporting further studies on miRPLND.

WORLD JOURNAL OF UROLOGY (2022)

No Data Available